DURECT
DURECT is a biopharmaceutical company committed to transforming the treatment of acute organ injury and chronic liver diseases by advancing novel and potentially lifesaving therapies based on its endogenous epigenetic regulator program.
Org chart
Teams
View all
Discover similar companies
Spectrum Pharmaceuticals
Post IPO Equity • Henderson, United States
Insys Therapeutics
Post IPO Equity • Phoenix, United States
Catalyst Pharmaceuticals
Post IPO Equity • Coral Gables, United States
TRICIDA
Post IPO Equity • South San Francisco, United States
Emmaus Medical
Post IPO Equity • Torrance, United States
Alimera Sciences
Post IPO Equity • Alpharetta, United States
Adamas Pharmaceuticals
Post IPO Equity • Emeryville, United States
WRAP Technologies
Post IPO Equity • Tempe, United States
Century Therapeutics
Post IPO Equity • Philadelphia, United States
Passage Bio
Post IPO Equity • Philadelphia, United States
Celularity
Post IPO Equity • Florham Park, United States
Curiosity
Post IPO Equity • Silver Spring, United States
helps you hire
great candidates
It’s free to use - try it out today.